The role of nitric oxide and reactive nitrogen species in experimental ARDS

Sebastian Rehberg, Marc O. Maybauer, Dirk M. Maybauer, Lillian D. Traber, Perenlei Enkhbaatar, Daniel L. Traber

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The acute respiratory distress syndrome (ARDS) is associated with a mortality ranging between 40 - 80%. An effective drug therapy, however, is still missing. Many experimental models of ARDS exist enabling a better understanding of the underlying pathophysiology and allowing the establishment of novel therapeutic strategies for the treatment of patients suffering ARDS. Nitric oxide (NO) and reactive nitrogen species (RNS) are increasingly regarded as key substances within the development of ARDS. However, the definite pathomechanism is not completely understood. The purpose of this article is to review the latest results of experimental studies in reference to the role of NO and RNS in the pathogenesis of ARDS. In addition, current large animal models of ARDS are described and future therapeutic approaches are discussed.

Original languageEnglish (US)
Pages (from-to)18-29
Number of pages12
JournalFrontiers in Bioscience - Scholar
Volume2 S
Issue number1
StatePublished - Jan 1 2010

Fingerprint

Reactive Nitrogen Species
Adult Respiratory Distress Syndrome
Nitric Oxide
Drug therapy
Animals
Theoretical Models
Therapeutics
Animal Models
Drug Therapy
Mortality

Keywords

  • Acute Respiratory Distress Syndrome
  • Inhalation Injury
  • Nitric Oxide Reactive Nitrogen Species
  • Poly-(Adp-Ribose) Polymerase Inhibitor
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Rehberg, S., Maybauer, M. O., Maybauer, D. M., Traber, L. D., Enkhbaatar, P., & Traber, D. L. (2010). The role of nitric oxide and reactive nitrogen species in experimental ARDS. Frontiers in Bioscience - Scholar, 2 S(1), 18-29.

The role of nitric oxide and reactive nitrogen species in experimental ARDS. / Rehberg, Sebastian; Maybauer, Marc O.; Maybauer, Dirk M.; Traber, Lillian D.; Enkhbaatar, Perenlei; Traber, Daniel L.

In: Frontiers in Bioscience - Scholar, Vol. 2 S, No. 1, 01.01.2010, p. 18-29.

Research output: Contribution to journalArticle

Rehberg, S, Maybauer, MO, Maybauer, DM, Traber, LD, Enkhbaatar, P & Traber, DL 2010, 'The role of nitric oxide and reactive nitrogen species in experimental ARDS', Frontiers in Bioscience - Scholar, vol. 2 S, no. 1, pp. 18-29.
Rehberg S, Maybauer MO, Maybauer DM, Traber LD, Enkhbaatar P, Traber DL. The role of nitric oxide and reactive nitrogen species in experimental ARDS. Frontiers in Bioscience - Scholar. 2010 Jan 1;2 S(1):18-29.
Rehberg, Sebastian ; Maybauer, Marc O. ; Maybauer, Dirk M. ; Traber, Lillian D. ; Enkhbaatar, Perenlei ; Traber, Daniel L. / The role of nitric oxide and reactive nitrogen species in experimental ARDS. In: Frontiers in Bioscience - Scholar. 2010 ; Vol. 2 S, No. 1. pp. 18-29.
@article{df7e937997054528acad3de5f33b6997,
title = "The role of nitric oxide and reactive nitrogen species in experimental ARDS",
abstract = "The acute respiratory distress syndrome (ARDS) is associated with a mortality ranging between 40 - 80{\%}. An effective drug therapy, however, is still missing. Many experimental models of ARDS exist enabling a better understanding of the underlying pathophysiology and allowing the establishment of novel therapeutic strategies for the treatment of patients suffering ARDS. Nitric oxide (NO) and reactive nitrogen species (RNS) are increasingly regarded as key substances within the development of ARDS. However, the definite pathomechanism is not completely understood. The purpose of this article is to review the latest results of experimental studies in reference to the role of NO and RNS in the pathogenesis of ARDS. In addition, current large animal models of ARDS are described and future therapeutic approaches are discussed.",
keywords = "Acute Respiratory Distress Syndrome, Inhalation Injury, Nitric Oxide Reactive Nitrogen Species, Poly-(Adp-Ribose) Polymerase Inhibitor, Review",
author = "Sebastian Rehberg and Maybauer, {Marc O.} and Maybauer, {Dirk M.} and Traber, {Lillian D.} and Perenlei Enkhbaatar and Traber, {Daniel L.}",
year = "2010",
month = "1",
day = "1",
language = "English (US)",
volume = "2 S",
pages = "18--29",
journal = "Frontiers in Bioscience - Scholar",
issn = "1945-0516",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - The role of nitric oxide and reactive nitrogen species in experimental ARDS

AU - Rehberg, Sebastian

AU - Maybauer, Marc O.

AU - Maybauer, Dirk M.

AU - Traber, Lillian D.

AU - Enkhbaatar, Perenlei

AU - Traber, Daniel L.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The acute respiratory distress syndrome (ARDS) is associated with a mortality ranging between 40 - 80%. An effective drug therapy, however, is still missing. Many experimental models of ARDS exist enabling a better understanding of the underlying pathophysiology and allowing the establishment of novel therapeutic strategies for the treatment of patients suffering ARDS. Nitric oxide (NO) and reactive nitrogen species (RNS) are increasingly regarded as key substances within the development of ARDS. However, the definite pathomechanism is not completely understood. The purpose of this article is to review the latest results of experimental studies in reference to the role of NO and RNS in the pathogenesis of ARDS. In addition, current large animal models of ARDS are described and future therapeutic approaches are discussed.

AB - The acute respiratory distress syndrome (ARDS) is associated with a mortality ranging between 40 - 80%. An effective drug therapy, however, is still missing. Many experimental models of ARDS exist enabling a better understanding of the underlying pathophysiology and allowing the establishment of novel therapeutic strategies for the treatment of patients suffering ARDS. Nitric oxide (NO) and reactive nitrogen species (RNS) are increasingly regarded as key substances within the development of ARDS. However, the definite pathomechanism is not completely understood. The purpose of this article is to review the latest results of experimental studies in reference to the role of NO and RNS in the pathogenesis of ARDS. In addition, current large animal models of ARDS are described and future therapeutic approaches are discussed.

KW - Acute Respiratory Distress Syndrome

KW - Inhalation Injury

KW - Nitric Oxide Reactive Nitrogen Species

KW - Poly-(Adp-Ribose) Polymerase Inhibitor

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=77957316217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957316217&partnerID=8YFLogxK

M3 - Article

VL - 2 S

SP - 18

EP - 29

JO - Frontiers in Bioscience - Scholar

JF - Frontiers in Bioscience - Scholar

SN - 1945-0516

IS - 1

ER -